Colleen Draper

Title: Colleen Draper: Innovator in Personalized Weight Management

Introduction

Colleen Draper is a notable inventor in the field of personalized weight management. She has developed innovative methods that leverage genetic information to create tailored weight-loss programs. Her work aims to improve the effectiveness of weight management strategies by considering individual metabolic genotypes.

Latest Patents

Colleen Draper's latest patent application is titled "Genetic Markers For Weight Management And Methods Of Use Thereof." This application relates to methods and tests that allow for the establishment of personalized weight-loss programs for a subject based upon the subject's metabolic genotype in key metabolic genes. Kits and methods are disclosed for determining a subject's metabolic genotype, which may be used to select an appropriate therapeutic or dietary regimen or lifestyle recommendation based upon the likelihood of a subject's responsiveness to certain diets and activity levels. Such a personalized weight-loss program will have obvious benefits, yielding better results in terms of weight loss and weight maintenance compared to traditional weight-loss programs that do not take into account genetic information.

Career Highlights

Throughout her career, Colleen has worked with various companies, including Access Business Group International LLC and Orig3n, Inc. Her experience in these organizations has contributed to her expertise in the field of genetic research and weight management.

Collaborations

Colleen has collaborated with notable individuals such as Leon Wilkins and Gary Breton. These partnerships have likely enhanced her research and development efforts in personalized weight management.

Conclusion

Colleen Draper is a pioneering inventor whose work in personalized weight management has the potential to revolutionize how individuals approach weight loss. Her innovative methods, grounded in genetic research, offer a promising alternative to traditional weight-loss programs.